NEW YORK (AP) - A drug to treat severe postpartum depression showed positive results in a mid-stage study, sending shares developer Sage Therapeutics skyrocketing.
There are no approved drugs that specifically treat a type of depression that, according to the American Psychological Association, afflicts up to one in seven women who give birth.
Sage Therapeutics surges on postpartum depression drug study
Aucun commentaire:
Enregistrer un commentaire